Literature DB >> 17159100

Body mass index and the risk of Parkinson disease.

G Hu1, P Jousilahti, A Nissinen, R Antikainen, M Kivipelto, J Tuomilehto.   

Abstract

OBJECTIVE: To examine the association between body mass index (BMI) and the risk of Parkinson disease (PD).
METHODS: Study cohorts included 22,367 Finnish men and 23,439 women 25 to 59 years of age without a history of PD at baseline. Hazards ratios (HRs) of incident PD were estimated for different levels of BMI.
RESULTS: During a mean follow-up period of 18.8 years, 272 men and 254 women developed incident PD. After adjustment for confounding factors (age, study years, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, and alcohol, coffee, and tea consumption), the HRs of PD at different levels of BMI (<23, 23 to 24.9, 25 to 26.9, 27 to 29.9, and > or =30 kg/m(2)) were 1.00, 1.97 (95% CI: 1.21 to 3.22), 1.83 (95% CI: 1.12 to 2.99), 2.34 (95% CI: 1.45 to 3.78), and 2.44 (95% CI: 1.44 to 4.15) in men, and 1.00, 1.50 (95% CI: 0.95 to 2.37), 1.65 (95% CI: 1.05 to 2.59), 1.79 (95% CI: 1.15 to 2.80), and 1.77 (95% CI: 1.12 to 2.78) in women, and 1.00, 1.70 (95% CI: 1.23 to 2.37), 1.70 (95% CI: 1.23 to 2.37), 2.02 (95% CI: 1.46 to 2.79), and 2.03 (95% CI: 1.44 to 2.85) in men and women combined (adjusted also for sex). In both sexes combined, the multivariate-adjusted direct association between BMI and the risk of PD was present both in subjects aged 25 to 49 years and 50 to 59 years, in never smokers and smokers and in participants diagnosed PD before and after 65 years of age.
CONCLUSION: Body mass index is associated with a risk of Parkinson disease. The effect is graded and independent of other risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 17159100     DOI: 10.1212/01.wnl.0000247052.18422.e5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  69 in total

1.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

2.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

3.  Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models.

Authors:  Vinita G Chittoor-Vinod; Steffany Villalobos-Cantor; Hanna Roshak; Kelsey Shea; Leire Abalde-Atristain; Ian Martin
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

Review 4.  Food reward functions as affected by obesity and bariatric surgery.

Authors:  A C Shin; H-R Berthoud
Journal:  Int J Obes (Lond)       Date:  2011-09       Impact factor: 5.095

5.  Associations between cerebrovascular risk factors and parkinson disease.

Authors:  Benjamin R Kummer; Iván Diaz; Xian Wu; Ashley E Aaroe; Monica L Chen; Costantino Iadecola; Hooman Kamel; Babak B Navi
Journal:  Ann Neurol       Date:  2019-08-29       Impact factor: 10.422

6.  Obesity, diabetes, and risk of Parkinson's disease.

Authors:  Natalia Palacios; Xiang Gao; Marjorie L McCullough; Eric J Jacobs; Alpa V Patel; Tinisha Mayo; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2011-07-07       Impact factor: 10.338

Review 7.  Energy intake and exercise as determinants of brain health and vulnerability to injury and disease.

Authors:  Mark P Mattson
Journal:  Cell Metab       Date:  2012-11-15       Impact factor: 27.287

8.  Fat-free body mass but not fat mass is associated with reduced gray matter volume of cortical brain regions implicated in autonomic and homeostatic regulation.

Authors:  Christopher M Weise; Pradeep Thiyyagura; Eric M Reiman; Kewei Chen; Jonathan Krakoff
Journal:  Neuroimage       Date:  2012-09-10       Impact factor: 6.556

9.  Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis.

Authors:  Angeliki G Filippatou; Jeffrey Lambe; Elias S Sotirchos; Kathryn C Fitzgerald; Andrew Aston; Olwen C Murphy; Nicole Pellegrini; Nicholas Fioravante; Hunter Risher; Esther Ogbuokiri; Ohemaa Kwakyi; Brandon Toliver; Simidele Davis; Nicholas Luciano; Ciprian Crainiceanu; Jerry L Prince; Ellen M Mowry; Peter A Calabresi; Shiv Saidha
Journal:  Mult Scler       Date:  2020-04-16       Impact factor: 6.312

10.  Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.

Authors:  Zane B Andrews; Derek Erion; Rudolph Beiler; Zhong-Wu Liu; Alfonso Abizaid; Jeffrey Zigman; John D Elsworth; Joseph M Savitt; Richard DiMarchi; Matthias Tschoep; Robert H Roth; Xiao-Bing Gao; Tamas L Horvath
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.